BRAF mutation analysis by ARMS‐PCR refines thyroid nodule management

X Li, E Li, J Du, J Wang, B Zheng - Clinical endocrinology, 2019 - Wiley Online Library
Background Fine‐needle aspiration (FNA) of thyroid nodules leads to nearly 25%
indeterminate nodules, while BRAFV600E mutation helps to predicting papillary thyroid …

[HTML][HTML] BRAFV600E genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspiration

Y Lu, X Guo, M Yang, K Wang, G Cao, Y Liu, X Hou… - Scientific Reports, 2023 - nature.com
The preoperative diagnosis of thyroid nodules now routinely includes BRAF V600E genetic
testing in most provincial and municipal hospitals in China. This study identified the most …

[HTML][HTML] Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study

S Bardet, N Goardon, J Lequesne, D Vaur… - Endocrine, 2021 - Springer
Purpose The aim of this prospective study (ClinicalTrials. gov: NCT01880203) was to
evaluate the diagnostic and prognostic value of a 7-panel mutation testing in the aspirates of …

[HTML][HTML] Molecular characterization of thyroid follicular lesions in the era of “next-generation” techniques

ED Rossi, P Locantore, C Bruno… - Frontiers in …, 2022 - frontiersin.org
It is unequivocally recognized that thyroid nodules are frequently detected in the adult
population and mostly characterized by benign lesions (up to 70% of them), with only 5 …

Molecular profiling of thyroid nodules—are these findings meaningful, or merely measurable?: a review

LGT Morris - JAMA Otolaryngology–Head & Neck Surgery, 2020 - jamanetwork.com
Importance Advances in genomic technologies have facilitated the development of
sophisticated molecular diagnostic tests for thyroid nodules, in the hopes of better risk …

Approach to risk stratification for papillary thyroid carcinoma based on molecular profiling: institutional analysis

JI Staubitz, C Müller, A Heymans, C Merten, B Roos… - BJS open, 2023 - academic.oup.com
Background Currently, treatment recommendations for papillary thyroid carcinoma are not
based on the genetic background causing tumourigenesis. The aim of the present study was …

Clinical practice guidelines" Management of iodine deficiency disorders"

FM Abdulkhabirova, OB Bezlepkina… - Problemy …, 2021 - europepmc.org
[Clinical practice guidelines "Management of iodine deficiency disorders"]. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

[HTML][HTML] The use of fine-needle aspiration (FNA) cytology in patients with thyroid nodules in Asia: a brief overview of studies from the Working Group of Asian Thyroid …

CK Jung, SW Hong, A Bychkov… - Journal of Pathology …, 2017 - synapse.koreamed.org
Ultrasound-guided fine-needle aspiration (FNA) cytology is the most widely used screening
and diagnostic method for thyroid nodules. Although Western guidelines for managing …

[HTML][HTML] BRAFV600E vs. TIRADS in predicting papillary thyroid cancers in Bethesda system I, III, and V nodules

Y Wu, T Xu, X Cao, X Zhao, H Deng… - Cancer biology & …, 2019 - ncbi.nlm.nih.gov
Objective Bethesda System for Reporting Thyroid Cytopathology (BSRTC) categories I, III,
and V account for a significant proportion of fine needle aspiration cytology (FNAC) …

Quantifying the differences in surgical management of patients with definitive and indeterminate thyroid nodule cytology

R Stewart, YJ Leang, CR Bhatt, S Grodski… - European Journal of …, 2020 - Elsevier
Introduction Thyroid nodules are increasingly common. Despite being an essential pre-
operative diagnostic tool, up to 30% of fine needle aspirate cytology (FNAC) yields a non …